Services
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) Vector Copy Number Analysis (qPCR, ddPCR) Service
Are you currently facing challenges in accurately assessing vector biodistribution, transgene expression, or quality control in your gene therapy projects? Our NHP Vector Copy Number (qPCR, ddPCR) service helps you accelerate your drug discovery process and ensure regulatory compliance by providing precise and reliable quantification of virus vectors in non-human primate (NHP) models. Through advanced digital PCR technology and a robust, validated workflow, we help you overcome variability and obtain absolute, reproducible data.
Introduction to NHP Vector Copy Number Analysis
What Our Service Is
Our NHP Vector Copy Number service provides a comprehensive solution for quantifying AAV vectors with unparalleled precision. This service is a critical step in gene therapy development, as it directly measures the number of vector genomes present in a given sample, a fundamental metric for evaluating vector biodistribution and shedding. Leveraging both qPCR and ddPCR, we offer a powerful and complementary approach to meet the specific needs of your project. Our services are essential for a variety of applications, including:
- Vector Biodistribution Studies: Accurately mapping the spread of AAV vectors throughout NHP tissues and fluids following administration.
- Gene Expression Analysis: Quantifying the presence of viral mRNA (transgene expression) to confirm therapeutic activity in target tissues.
- Vector Shedding and Safety Studies: Monitoring the shedding of AAV vectors from the body to support safety assessments.
Why Choose Us?
Gene therapy development in non-human primates is a complex and high-stakes endeavor. Many research teams struggle with traditional qPCR methods, which can produce variable and inconsistent data due to the need for standard curves and sensitivity to inhibitors. Creative Biolabs solves this with a dual-platform strategy that includes ddPCR. This method provides absolute quantification by counting individual molecules, which eliminates the need for a standard curve and results in more precise and reproducible data. By choosing us, you gain a partner that provides the accuracy and expertise required to navigate the complexities of gene therapy development.
Distributed under Unsplash License, from Unsplash.
Key Benefits of Our Service
Creative Biolabs' NHP Vector Copy Number service is built on a foundation of scientific rigor and an unwavering commitment to data quality. Our unique strengths ensure your project moves forward with speed and confidence.
- Absolute Quantification with ddPCR: Our primary advantage lies in the use of droplet digital PCR. This technology partitions each sample into thousands of tiny droplets, each acting as a separate PCR reaction. The method provides an absolute count of target molecules, delivering more precise and reliable results, especially for low-copy number targets.
- NHP Expertise and Resources: Non-human primates are the gold standard for preclinical gene therapy studies due to their biological and genetic similarities to humans. Our services are specifically optimized for NHP tissues, ensuring high-quality results that are highly translatable to the clinic. We have extensive experience handling a wide variety of NHP sample types and are a trusted resource for researchers worldwide.
- Rapid Turnaround Time and Scalability: We understand that speed is crucial in drug development. Our enhanced automation and optimized workflows allow for a typical turnaround time of 7-14 business days, even for high-throughput projects. We can process a large number of samples annually without compromising on quality or precision.
- Customization and Reporting Depth: We work with you to design a custom assay tailored to your specific AAV vector and project goals. Our final reports are comprehensive and include raw data, detailed statistical analyses, and expert interpretation to provide a complete picture of your study.
How Creative Biolabs' NHP Services Can Assist Your Project?
Our service provides a clear, step-by-step pathway to reliable data, removing the guesswork from your preclinical studies.
01
Required Starting Materials
02
Project Scoping and Assay Design
03
Sample Receipt and Quality Control
04
Nucleic Acid Extraction
05
Vector Quantification
06
Data Analysis and Reporting
Key Deliverables
- A comprehensive lab report detailing methods, materials, and results.
- Raw data files from both qPCR and ddPCR platforms.
- Statistical analysis of vector copy numbers, including standard deviation and confidence intervals.
- Expert interpretation of the data, including a summary of key findings and their implications.
Capabilities & Partnerships
Service-Specific Data
- Annual Sample Size: Over 50,000 samples analyzed per year.
- Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
- Study Pass Rate: 99%+ success rate in meeting study endpoints.
Our Valued Partners
Frequently Asked Questions
Q: Why is vector copy number so critical for my gene therapy project?
A: Vector copy number is a fundamental metric that helps you understand the fate of your therapeutic vector after it is administered. It tells you where the vector goes (biodistribution), if it stays in the target tissue long enough to be effective, and if it is shedding into other parts of the body, which is important for safety and regulatory approval.
Q: How does Creative Biolabs' ddPCR service compare to traditional qPCR?
A: While qPCR is a good screening tool, ddPCR offers superior precision and absolute quantification without the need for a standard curve. This makes the data more reproducible and reliable, especially for low-level targets or complex samples where inhibitors may be present. We use both technologies to provide the most comprehensive and robust data set for your project.
Q: What types of samples do you accept for analysis?
A: We have validated protocols for a wide range of NHP samples, including various tissues (e.g., liver, muscle, brain), as well as bodily fluids like blood, cerebrospinal fluid, and urine. If you have a unique sample type, please reach out to our team to discuss customization.
Q: How do you ensure the quality and reliability of your data?
A: Our workflow includes multiple quality control checks, from sample receipt to final data analysis. We use validated assays, robust instrumentation, and redundant checks to ensure accuracy. The inherent precision of ddPCR also helps minimize technical variability, giving you high-quality data that you can trust.
Q: Can Creative Biolabs help me if my project is still in the early stages?
A: Absolutely. We offer flexible services that can be tailored to projects at any stage, from early-stage research to preclinical development. Our scientific team is here to guide you, from initial assay design and material requirements to data interpretation. We encourage you to contact us to discuss how we can best support your unique project.
Contact Us
Creative Biolabs provides industry-leading solutions for gene therapy development, combining cutting-edge technology with scientific expertise. Our NHP Vector Copy Number (qPCR, ddPCR) service is designed to deliver the precise, reproducible, and reliable data you need to drive your project from preclinical to clinical success. Contact our team today for more information and to discuss your specific project.